 |
|
The Harvard Medical
School Genetics Training Program is accredited by the American Board of
Medical Genetics to provide training in Clinical Molecular Genetics. Participating
laboratories are at Children's Hospital, Massachusetts General Hospital,
Brigham and Women's Hospital and Genzyme Genetics.
The overall goals of the molecular genetics program are:
- understand the
principles of molecular genetics as applied to diagnostic testing, including
direct mutation analysis and linkage analysis
- become familiar
with major techniques used in clinical molecular genetics, including
PCR, Southern analysis, DNA sequencing, electrophoresis, and other technologies
- learn the major
clinical indications for molecular testing and the clinical implications
of test results
- learn to calculate
genetic risks and integrate molecular and clinical data
- develop skills
in communicating with referring physicians
- become familiar
with clinical disorders amenable to molecular testing
- appreciate the
issues in quality assurance necessary to management of a diagnostic
laboratory
- become sensitive
to ethical issues in genetics, particularly those raised by molecular
diagnostic testing
- participate in
an ongoing research activity in molecular genetics
The following is a
sample schedule of the molecular genetics program. Click on the laboratories
to view the laboratory's website.

Description of Training Sites
Brigham
and Women's Hospital Diagnostic Molecular Biology Laboratory
| Location: |
Brigham
and Women's Hospital, Boston |
| Faculty: |
Jeffrey
Sklar, M.D., Ph.D., Director |
| |
Janina
Longtine, MD, Clinical Director |
Test
Offerings:
|
B-cell
clonality, T-cell clonality, BCR/ABL, PML/RARA, Factor V Leiden, Prothrombin
20210G |
Fellows are responsible for presentation of cases at the weekly laboratory
meeting. Presentations include review of clinical history and/or pathologic
diagnosis as well as testing results and any technical issues associated
with the test. Fellows are required to draft reports for cases and to
communicate results directly to referring physicians. This communication
is discussed with the attending DMB pathologist prior to its delivery
and is performed under direct supervision. Fellows also expected to become
familiar with all the laboratory protocols and to update the literature
on one disease. The fellow must present this update during one lab meeting.
During the rotations
in the three Harvard Medical School laboratories, the fellows are expected
to make monthly presentations at the Genetics Walk Rounds held at 10:00
am on Wednesday mornings at Children’s Hospital. These presentations are
based on current clinical cases in which the fellow is involved.
Fellows are also required
to attend Partners Cancer Genetics Clinic at Dana Farber Cancer Institute
on Fridays. Even though there is no direct relationship between the two,
fellows will see some patients with same disorders that are tested in
the lab. Due to the close proximity of the BWH to DFCI, it is easy for
fellows to attend the Cancer Genetics clinic while doing a rotation at
the DMB Lab.
Children's Hospital DNA Diagnostic Laboratory
| Location: |
Children's
Hospital, Boston |
| Faculty: |
Bai-Lin
Wu, Ph.D., Director |
| |
Alan
Beggs , Ph.D. |
Test
Offerings:
|
Duchenne/Becker
Dystrophy (Proband Analysis, Carrier Analysis and Linkage Analysis),
Prader-Willi/Angelman Syndrome (Methylation Analysis), Fragile X
Syndrome, Cystic Fibrosis, MELAS, Y Chromosome Deletion Analysis,
Neurofibromatosis 1 Deletion Analysis, Factor V Leiden, Connexin
26 and Uniparental Disomy Analysis for all chromosomes
|
Through out the rotation,
fellows review test results, draft reports for sign-out and perform bench
work for clinical tests. Fellows are also required to attend the Genetics
Clinic at Children’s Hospital with Dr. Gerry Cox on Mondays.
Fellows in the Molecular
Training Program are expected to complete a project involving either the
development of a new diagnostic test or the modification of current methodology
during this rotation.
Genzyme
Genetics Molecular Diagnostic Laboratory
| Location: |
Framingham,
MA (Westborough, MA as of Fall 2002) |
| Faculty: |
D.
Alexa Sirko-Osadsa, Ph.D., Molecular Laboratory Director |
Test
Offerings:
|
Angelman Syndrome
(uniparental disomy and methylation), B-cell clonality, Bcl-2, bcr-abl,
Bloom Syndrome, Canavan Disease, Cystic Fibrosis (87 mutations and
polyT polymorphism), Factor II (prothrombin G20210A), Factor V Leiden,
Familial Dysautonomia, Fanconi Anemia, Fragile X Syndrome, Gaucher
Disease, Hemoglobin C, Hemoglobin S, Hemophilia A/Factor VIII inversion,
Huntington Disease, MTHFR (C677T), Mucolipidosis type IV, Niemann-Pick
Disease, Prader-Willi Syndrome (uniparental disomy and methylation),
T-cell clonality, Rhc/RhE and RhD genotyping, Tay-Sachs Disease,
twin zygosity studies, Y microdeletion analysis
|
Fellows train in
a high volume, high throughput, clinical molecular diagnostics laboratory,
where they have the opportunity to experience the scope of information
management, specimen tracking, automation, assay workflow and quality
control associated with the demands of this unique environment. Our laboratory
uses a variety of diagnostic testing methods, ranging from classical Southern
blotting to fluorescence-based allele-discrimination platforms. Six board-certified
clinical molecular geneticists and seven board-certified genetic counselors
are on site.
During this rotation,
fellows will spend time in our Accessioning, Extraction, Assay, Reporting,
Quality Control, and Development laboratories and will review assay results
with Lab Directors and Genetic Counselors. The number of patient specimens
we analyze provides an increased opportunity to be involved in abnormal
and unusual cases that might not be encountered in a small laboratory
setting.
While in the lab,
rotating fellows will be expected to present a seminar as part of our
continuing education program and to work on an individual research or
development project.
MGH
Neurogenetics DNA Diagnostic Laboratory
Location:
|
Massachusetts
General Hospital East; Charlestown, MA |
| Faculty: |
Katherine
B. Sims, MD, Director |
| |
Winnie
Xin, Ph.D., Laboratory Supervisor |
Test
Offerings:
|
Dystonia (DYT1),
Familial Amyotrophic Lateral Sclerosis (SOD1 mutation), Hypokalemic
Periodic Paralysis, Hyperkalemic Periodic Paralysis, Infantile Neuronal
Ceroid Lipofuscinosis, Late Infantile Neuronal Ceroid Lipofuscinosis,
Juvenile Neuronal Ceroid Lipofuscinosis, Neurofibromatosis type
2, Tuberous Sclerosis (TSC1 and TSC2), Huntingdon disease, Freiderichs
Ataxia, Spinocerebellar ataxias, Machado-Joseph disease, Dentatorubral-pallidoluysian
atrophy, paternity and chromosome 1p allele loss
|
Through out the rotation,
fellows review new cases, laboratory test results and reports. Fellows
are afforded the opportunity to discuss the laboratory services, protocols
and results with referring physicians. At the weekly laboratory meeting,
fellows have primary responsibility for presentation of current cases.
Fellows also are requested to update one disease literature notebook with
recently published articles and to present these findings to the laboratory.
Finally, fellows work at the bench, processing clinical samples and setting
up new diagnostic tests.
|
|